[Retracted] Mesenchymal Stem Cell-Derived Exosomes and Their Potential Agents in Hematological Diseases

Figure 3

Schematic diagram of molecular mechanisms MSC-exosomes in hematological diseases. (a) The action of MSC-exosomes and subsequent clinical outcomes in GVHD. (b) A brief outline of exosomal cargoes and underlying mechanisms of MSC-exosomes in MM. (c) Exosomal loadings and potential effects of MSC-exosomes in the diseases of AML, CML, and CLL. HLA-G: human leukocyte antigen-G; cGVHD: chronic GVHD; MM: multiple myeloma; AML: acute myeloid leukemia; CML: chronic myeloid leukemia, CLL: chronic lymphocytic leukemia; PIs: proteasome inhibitors; IM: imatinib.